Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;18(3):153-162.
doi: 10.1007/s11897-021-00508-z. Epub 2021 Apr 4.

Catheter Ablation of Atrial Fibrillation in Heart Failure: from Evidences to Guidelines

Arianna Cirasa  1 , Carmelo La Greca  2 , Domenico Pecora  2
Affiliations
Review

Catheter Ablation of Atrial Fibrillation in Heart Failure: from Evidences to Guidelines

Arianna Cirasa et al. Curr Heart Fail Rep. 2021 Jun.

Abstract

Purpose of review: Catheter ablation of atrial fibrillation in heart failure seems to be the way to improve the quality of life, life expectance, and prognosis. In this review, we outline the growing role of this therapy and which patients can benefit from it.

Recent findings: While previous studies comparing rate control and rhythm control had not demonstrated the superiority of rhythm control in the prognosis of patients with atrial fibrillation and heart failure, recent findings seem to demonstrate that catheter ablation of atrial fibrillation reduces mortality and hospitalization for heart failure and improves the quality of life, when compared to medical therapy alone. An early rhythm-control strategy in atrial fibrillation may reduce cardiovascular death, stroke, hospitalization for HF, or acute coronary syndrome. Catheter ablation in heart failure is an effective and safe solution to obtain a rhythm control and, therefore, to improve outcomes. A better selection of the patients could help to avoid futile procedures and to identify patients requiring a closer follow-up, to redo procedures, or the addition of antiarrhythmic drugs.

Keywords: Atrial fibrillation; Catheter ablation; Heart failure.

PubMed Disclaimer

References

Papers of particular interest, published recently, have been highlighted as: • Of importance
    1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020:ehaa612. https://doi.org/10.1093/eurheartj/ehaa612 .
    1. Ziff OJ, Carter PR, McGowan J, Uppal H, Chandran S, Russell S, et al. The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: insights from the, United Kingdom ACALM registry. Int J Cardiol. 2018;252:117–21. https://doi.org/10.1016/j.ijcard.2017.06.033 . - DOI - PubMed
    1. Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, et al. Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 2016;133(5):484–92. https://doi.org/10.1161/CIRCULATIONAHA.115.018614 . - DOI - PubMed - PMC
    1. Calkins H, Hindricks G, Cappato R, Kim Y-H, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14:e275–444. https://doi.org/10.1093/europace/eux274 . - DOI - PubMed - PMC
    1. Balla C, Cappato R. Atrial fibrillation ablation in heart failure. Eur Heart J Suppl. 2020;22(Suppl E):E50–3. https://doi.org/10.1093/eurheartj/suaa059 . - DOI - PubMed - PMC

Substances

LinkOut - more resources